{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319362814976.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1124/dmd.111.044420"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0090955624226775?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0090955624226775?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1124/dmd.111.044420"}}],"dc:title":[{"@value":"Use of the Cassette-Dosing Approach to Assess Brain Penetration in Drug Discovery"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670319362814978","@type":"Researcher","foaf:name":[{"@value":"Xingrong Liu"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319362814848","@type":"Researcher","foaf:name":[{"@value":"Xiao Ding"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319362814979","@type":"Researcher","foaf:name":[{"@value":"Gauri Deshmukh"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319362814976","@type":"Researcher","foaf:name":[{"@value":"Bianca M. Liederer"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021798695039616","@type":"Researcher","foaf:name":[{"@value":"Cornelis E.C.A. Hop"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00909556"}],"prism:publicationName":[{"@value":"Drug Metabolism and Disposition"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2012-05","prism:volume":"40","prism:number":"5","prism:startingPage":"963","prism:endingPage":"969"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0090955624226775?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0090955624226775?httpAccept=text/plain"},{"@id":"https://syndication.highwire.org/content/doi/10.1124/dmd.111.044420"}],"createdAt":"2012-02-11","modifiedAt":"2025-02-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360567182509684224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possibility of Predicting Serotonin Transporter Occupancy From the In Vitro Inhibition Constant for Serotonin Transporter, the Clinically Relevant Plasma Concentration of Unbound Drugs, and Their Profiles for Substrates of Transporters"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848655125743488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cocktail-Dosing Microdialysis Study to Simultaneously Assess Delivery of Multiple Organic–Cationic Drugs to the Brain"}]},{"@id":"https://cir.nii.ac.jp/crid/1361978698490709888","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Metabolism of KO143, an ABCG2 inhibitor"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1124/dmd.111.044420"},{"@type":"CROSSREF","@value":"10.1002/jps.24691_references_DOI_1fn7kyuvJVxzZRtmnsYZmm2WOQl"},{"@type":"CROSSREF","@value":"10.1016/j.xphs.2017.05.007_references_DOI_1fn7kyuvJVxzZRtmnsYZmm2WOQl"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2017.02.003_references_DOI_1fn7kyuvJVxzZRtmnsYZmm2WOQl"}]}